SYNC-T Immunotherapy Platform Shows Promise in Prostate Cancer Treatment
The SYNC-T immunotherapy platform, developed for advanced prostate cancer treatment, utilizes a four-part mechanism to target tumor cells, according to reports from the American Journal of Managed Care (AJMC). Researchers ... Read More